Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone Therapy in Chronic Stable Right HF Trial
NCT03344159Phase 4Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Apr 2018
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in heart failure (HF), sponsored by University of Ottawa Heart Institute. Started Apr 2018; status: completed.
02
Drugs
spironolactone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03344159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03344159.